Oppenheimer points out the next "trend" in weight loss drugs: oral over-the-counter medications.

The competition to develop oral weight loss drugs is heating up.

Zhitong FinanceSep 26 10:38

Why Viking Therapeutics Stock Was So Healthy on Wednesday

Yahoo FinanceSep 26 06:08

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Yahoo FinanceSep 26 05:50

Next Frontier in Anti-obesity Landscape: Oral GLP-1s With Potential OTC Switch

Seeking AlphaSep 26 02:55

Viking Therapeutics Analyst Ratings

BenzingaSep 26 01:49 · Ratings

Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $138

Futu NewsSep 26 00:31 · Ratings